Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma

Cancer

Volumn 92, Issue 4, 2001, Pages 720-729

  Daling, Janet R ^a,b   Malone, Kathleen E ^a,b   Doody, David R ^a   Johnson, Lisa G ^a   Gralow, Julie R ^c   Porter, Peggy L ^a,c  

^a USA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Body mass index (BMI); Breast carcinoma; Survival; Tumor markers; Young women

Indexed keywords

CYCLIN E; ESTROGEN RECEPTOR; KI 67 ANTIGEN; ONCOPROTEIN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P27; PROTEIN P53; TUMOR MARKER;

ADULT; AGE; ARTICLE; BODY MASS; BREAST CARCINOMA; CANCER GRADING; CANCER INVASION; CANCER MORTALITY; CELL CYCLE S PHASE; CELL PROLIFERATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS; OBESITY; PREMENOPAUSE; PRIORITY JOURNAL; PROGNOSIS; SURVIVAL RATE; TUMOR VOLUME;

ADULT; BODY MASS INDEX; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; OBESITY; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035880693     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010815)92:4<720::AID-CNCR1375>3.0.CO;2-T     Document Type: Article

References (36)

1. Relation between obesity and breast cancer in young women
2. Body size and breast cancer risk among women under age 45 years
3. A meta-analysis of body mass index and risk of premenopausal breast cancer
4. Relative weight and risk of breast cancer among premenopausal women
5. Body size and breast cancer risk assessed in women participating in the Breast Cancer Detection Demonstration Project
6. Early body size and subsequent weight gain as predictors of breast cancer incidence (Iowa, United States)
7. Risk factors for breast cancer
8. Diet, body size, and cancer
9. The effect of body mass index and oestrogen receptor level on survival of breast cancer patients
10. Body size and breast cancer prognosis: A critical review of the evidence
11. Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients
12. Body size and survival in premenopausal breast cancer
13. Survival of women with node negative breast cancer in the Auckland region
14. Oral contraceptives and prognosis in breast cancer: Effects of duration, latency, recency, age at first use, and relation to parity and body mass index in young women with breast cancer
15. Relation between steroid receptor status and body weight in breast cancer patients
16. Estrogen and progesterone receptors in breast cancer patients. Epidemiologic characteristics and survival differences
17. p53 protein overexpression in relation to risk factors for breast cancer
18. Risk of breast cancer among young women: Relationship to induced abortion
19. Oral contraceptives and breast cancer risk among younger women
20. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
21. Breast tumor characteristics as predictors of mammographic detection: Comparison of interval-andscreen-detected cancers
22. Cytokeratin labeling of breast cancer cells extracted from paraffin embedded tissue for bivariate flow cytometric analysis
23. The accuracy of self-reported weights
24. Self-reported weight and height
25. Body mass definitions of obesity: Sensitivity and specificity using self-reported weight and height
26. Underestimation of relative weight by use of self-reported height and weight
27. Overweight is risking fate: Definition, classification, prevalence, and risks
28. Body-size indicators and risk of breast cancer according to menopause and estrogen-receptor status
29. Body weight, serum cholesterol, and stage of primary breast cancer
30. Body size physical activity, and breast cancer hormone receptor status: Results from two case-control studies
31. Stage of breast cancer in relation to body mass index and bra cup size
32. Recurrence of breast cancer: Obesity, tumor size and axillary lymph node metastases
33. Screening for cervical and breast cancer: Is obesity an unrecognized barrier to preventive care?
34. Effect of obesity on conversion of plasma androstenedione to estrone in postmenopausal women with and without endometrial cancer
35. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk
36. Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status